Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 878 All time
- Disclosed funding
- $34.1B 792 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TARCompany profile Modular off-grid power systems help AI data centers secure dependable electricity outside constrained grids. Modular off-grid power systems help AI data centers secure dependable electricity outside constrained grids. | $120M | Series A | Climate tech | United States | Investors | |
| I IvexCompany profile IVEX provides software that analyzes real-world vehicle data to test and validate advanced driver-assistance and autonomous-driving systems, helping automotive engineers assess safety performance with traceable evidence. IVEX provides software that analyzes real-world vehicle data to test and validate advanced driver-assistance and autonomous-driving systems, helping automotive engineers assess safety performance with traceable evidence. | €5M | Series A | Mobility | Belgium | Investors | |
| AA Arlequin AICompany profile An AI data-analysis platform for governments and large organisations that connects fragmented records and surfaces traceable relationships for consequential decisions. An AI data-analysis platform for governments and large organisations that connects fragmented records and surfaces traceable relationships for consequential decisions. | €28M | Series A | AI | France | Investors | |
| E EunoCompany profile An AI context platform maps enterprise data meaning, lineage and governance so agents can use the right information safely. An AI context platform maps enterprise data meaning, lineage and governance so agents can use the right information safely. | $23M | Series A | AI | United States | Investors | |
| QL QNu LabsCompany profile Quantum-safe security products for organisations protecting sensitive communications and data. Quantum-safe security products for organisations protecting sensitive communications and data. | ₹2B | Series A1Series A | Cybersecurity | India | Investors | |
| HE HVR EnergyCompany profile HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. | €20M | Series A | Mobility | Spain | Investors | |
| A AquaCompany profile Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. | $15M | Series A | Fintech | United States | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors | |
| TT TwoStep TherapeuticsCompany profile A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. | $62.5M | Series A | Biotech | United States | Investors | |
| Z ZeroRiskCompany profile A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. | $10M | Series A | Cybersecurity | Ireland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.